eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
2/2013
vol. 10
 
Share:
Send email
Share:
abstract:

EXPERIMENTAL CARDIOVASCULAR AND LUNG RESEARCH
From mutation to methylation – molecular markers in lung cancer

Marzena Anna Lewandowska
,
Katarzyna Grębicka
,
Agnieszka Chrustek
,
Ilona Kujawska
,
Aleksandra Zaleska
,
Janusz Kowalewski

Kardiochirurgia i Torakochirurgia Polska 2013; 10 (2): 148–153
DOI: https://doi.org/10.5114/kitp.2013.36136
Online publish date: 2013/07/09
View full text Get citation
 
PlumX metrics:
Lung cancer is one of the most common types of malignant neoplasms in Poland and in the world, and is associated with the worst prognosis. Within recent years, significant progress has been made when it comes to high-throughput and high-resolution technologies in the field of molecular biology, i.e. next-generation sequencing, microarrays, and mass spectrometry, which contributed to the development of research in the fields of genomics, transcriptomics and epigenetics in lung cancer. Implementing the results achieved by these disciplines quickly allows for the analysis of somatic point mutations or translocations to be used in molecular cancer diagnostics, and, thus, for the personalization of treatment for patients with non-small cell lung cancer (NSCLC). Unfortunately, certain markers and prognostic predictors that could facilitate the detection of lung cancer in its early stages are yet to be found.
keywords:

molecular biomarkers, personalized oncology, molecular diagnostics
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.